Source link : https://newshealth.biz/health-news/more-evidence-lowering-amyloid-is-beneficial-in-early-ad/
A secondary analysis of TRAILBLAZER-ALZ 2 strengthens the case that reducing amyloid plaques underlies the clinical benefits of donanemab in early Alzheimer’s disease. Medscape Medical News Source link : https://www.medscape.com/viewarticle/more-evidence-lowering-amyloid-clinically-beneficial-early-2025a1000s05?src=rss Author : Publish date : 2025-10-16 13:27:00 Copyright for syndicated content belongs to the linked Source.
The post More Evidence Lowering Amyloid Is Beneficial in Early AD first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-16 13:27:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8